Vistagen Therapeutics (VTGN) Q4 2024 Earnings

Nov 7Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.42
-0.18
0.06
0.3

Details

Expected EPS
-0.390825
Actual EPS
-0.42
Surprise EPS
-0.03
Surprise Percent
-7.46%

Description

⁨Vistagen Therapeutics⁩ (⁦VTGN⁩) has reported earnings of ⁦-0.42⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts